The benefits of fiber in celiac disease may depend on having the right bacteria in the gut
15 May 2026by GMFH Editing Team
The gluten-free diet for celiac disease can be low in fiber. Researchers from McMaster University showed that people with celiac disease had reduced capacity to metabolize dietary fiber in the small intestine because they lack key fiber-degrading bacteria.
The gut microbiota “signature”: the key to the Mediterranean diet’s role in slowing cognitive decline
22 Apr 2026by Cristina Sáez
The Mediterranean diet is once again at the center of scientific evidence. A new study, published in BMC Medicine, shows that this dietary pattern not only protects cardiovascular and metabolic health, but also helps preserve cognitive function with age.
Intermittent fasting has become increasingly popular as a dietary approach for improving metabolic and gut health. This article explores the potential benefits and risks of intermittent fasting for the gut, examining current evidence on its effects on digestion, the gut microbiota, and overall health.
Stay tuned to our latest news
Food 4 Gut Health news
One in four adults experience digestive symptoms that impact quality of life
15 Jun 2026by Andreu Prados
Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.
Dietary fiber is often seen as essential for gut health. However, is it always beneficial? New research challenges this idea, highlighting that not all fibers act the same and that context, type, and dose matter.
Research & Practice news
One in four adults experience digestive symptoms that impact quality of life
15 Jun 2026by Andreu Prados
Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.
From regulation to opportunity: shaping the future of microbiome-based therapies in Europe
8 Jun 2026by Konstantina Zafeiropoulou
The European regulatory landscape for microbiome-based therapies is rapidly evolving. New frameworks like the SoHO Regulation aim to harmonize safety, quality, and access across countries. This article explores the current challenges, opportunities, and expert perspectives shaping the field.
Rethinking diet and the gut microbiome in IBD: from risk to treatment and beyond
28 May 2026by GMFH Editing Team
The role of diet and the gut microbiome in inflammatory bowel disease (IBD) continues to evolve, from shaping disease risk to supporting treatment strategies. In this interview with Richard Hansen and Chen Sarbagili, we discuss key misconceptions, emerging evidence, and what the future may hold for microbiome-based approaches in IBD.
